MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 4 (2007), Issue 11 (November)

1. Prevalence and demographics of methicillin resistant staphylococcus aureus in culturable skin and soft tissue infections in an urban emergency department.
   BMC Emerg Med, 7(1): 19. [Abstract] [Full-text]
2. Complicated Community-Acquired Soft Tissue Infection by MRSA from Porcine Origin.
   Infection. [Abstract] [Full-text]
3. Cluster of methicillin-resistant Staphylococcus aureus colonization in a small animal intensive care unit.
   J Am Vet Med Assoc, 231(9): 1361-4. [Abstract] [Full-text]
4. Clinical features and molecular characteristics of invasive community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children.
   Diagn Microbiol Infect Dis, 59(3): 287-93. [Abstract] [Full-text]
5. Detection and characterization of international community-acquired infections by methicillin-resistant Staphylococcus aureus clones in Rio de Janeiro and Porto Alegre cities causing both community- and hospital-associated diseases.
   Diagn Microbiol Infect Dis, 59(3): 339-45. [Abstract] [Full-text]
6. Performance of MRSA ID chromogenic medium for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures and clinical specimens.
   Diagn Microbiol Infect Dis, 59(3): 319-23. [Abstract] [Full-text]
7. Complicated adult epiglottitis due to methicillin-resistant Staphylococcus aureus.
   Am J Otolaryngol, 28(6): 441-443. [Abstract] [Full-text]
8. Bactericidal activity of denture-cleaning formulations against planktonic health care-associated and community-associated methicillin-resistant Staphylococcus aureus.
   Am J Infect Control, 35(9): 619-22. [Abstract] [Full-text]
9. Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.
   Am J Infect Control, 35(9): 563-8. [Abstract] [Full-text]
10. Overlapping population structures of nasal isolates of Staphylococcus aureus from healthy Dutch and American individuals.
    J Clin Microbiol. [Abstract] [Full-text]
11. A randomized Phase I study of Atuna racemosa: a potential new anti-MRSA natural product extract.
    J Ethnopharmacol, 114(3): 371-6. [Abstract] [Full-text]
12. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period.
    J Clin Microbiol, 45(11): 3729-36. [Abstract] [Full-text]
13. Temporal relationship between prevalence of meticillin-resistant Staphylococcus aureus (MRSA) in one hospital and prevalence of MRSA in the surrounding community: a time-series analysis.
    J Hosp Infect, 67(3): 225-31. [Abstract] [Full-text]
14. Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit.
    J Hosp Infect, 67(3): 232-9. [Abstract] [Full-text]
15. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus.
    BMC Microbiol, 7(1): 99. [Abstract] [Full-text]
16. PVL-positive MRSA in Austria.
    Eur J Clin Microbiol Infect Dis, 26(12): 931-5. [Abstract] [Full-text]
17. Telavancin: a novel lipoglycopeptide antimicrobial agent.
    Am J Health Syst Pharm, 64(22): 2335-48. [Abstract] [Full-text]
18. Methicillin-resistant Staphylococcus aureus hepatic abscess in a patient with sickle-cell disease.
    Int J Lab Hematol, 29(6): 474-7. [Abstract] [Full-text]
19. High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus.
    Clin Microbiol Infect, 13(12): 1157-64. [Abstract] [Full-text]
20. Molecular typing of Staphylococcus aureus clinical isolates by pulsed-field gel electrophoresis, staphylococcal cassette chromosome mec type determination and dissemination of antibiotic resistance genes.
    Int J Antimicrob Agents, 30(6): 505-13. [Abstract] [Full-text]
21. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power.
    Curr Opin Microbiol, 10(5): 428-35. [Abstract] [Full-text]
22. New oxazolidinones.
    Curr Opin Microbiol, 10(5): 454-60. [Abstract] [Full-text]
23. Staphylococcus aureus colonization among healthcare workers at a tertiary care hospital.
    Infect Control Hosp Epidemiol, 28(12): 1404-7. [Abstract] [Full-text]
24. Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate.
    Burns, 33(8): 1008-14. [Abstract] [Full-text]
25. Evaluation of daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
26. The antimicrobial peptide-sensing system aps of Staphylococcus aureus.
    Mol Microbiol, 66(5): 1136-47. [Abstract] [Full-text]
27. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital.
    Am J Surg, 194(6): 809-12; discussion 812-3. [Abstract] [Full-text]
28. Molecular and epidemiological evidence for spread of multiresistant methicillin-susceptible Staphylococcus aureus strains in hospitals.
    Antimicrob Agents Chemother, 51(12): 4342-50. [Abstract] [Full-text]
29. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries.
    J Antimicrob Chemother, 60(6): 1310-5. [Abstract] [Full-text]
30. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    J Antimicrob Chemother, 60(6): 1361-9. [Abstract] [Full-text]
31. Effect of human plasma on the antimicrobial activity of iclaprim in vitro.
    J Antimicrob Chemother, 60(6): 1388-90. [Abstract] [Full-text]
32. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006.
    J Antimicrob Chemother, 60(6): 1258-63. [Abstract] [Full-text]
33. Is an increase of MRSA in Oslo, Norway, associated with changed infection control policy?
    J Infect. [Abstract] [Full-text]
34. Multiplex PCR for the Rapid Detection of Isolates Suspicious to be Community Acquired Staphylococcus aureus.
    J Clin Microbiol. [Abstract] [Full-text]
35. Acute rise in methicillin-resistant Staphylococcus aureus infections in a coastal community.
    Otolaryngol Head Neck Surg, 137(6): 942-6. [Abstract] [Full-text]
36. Clinical features, epidemiology, antimicrobial resistance, and exotoxin genes (including that of Panton-Valentine leukocidin) of gentamicin-susceptible methicillin-resistant Staphylococcus aureus (GS-MRSA) isolated at a paediatric teaching hospital in New South Wales, Australia.
    Pathology, 40(1): 64-71. [Abstract] [Full-text]
37. Inhibitory Activities of Eleven Antimicrobial Agents and Bactericidal Activities of Vancomycin and Daptomycin against Invasive Methicillin-Resistant Staphylococcus aureus (MRSA) from 1999 through 2006.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
38. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Expert Rev Anti Infect Ther, 5(6): 961-81. [Abstract] [Full-text]
39. Methicillin-resistant Staphylococcus aureus as a cause of extensive retropharyngeal abscess in two infants.
    Pediatr Infect Dis J, 26(12): 1161-3. [Abstract] [Full-text]
40. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Pediatr Infect Dis J, 26(12): 1128-32. [Abstract] [Full-text]
41. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections.
    Pediatr Infect Dis J, 26(12): 1122-7. [Abstract] [Full-text]
42. Novel targets for antibiotics in Staphylococcus aureus.
    Future Microbiol, 2: 655-66. [Abstract] [Full-text]
43. Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections: Clinical and Economic Outcomes.
    Pharmacotherapy, 27(12): 1611-8. [Abstract] [Full-text]
44. New antimicrobial agents as therapy for resistant gram-positive cocci.
    Eur J Clin Microbiol Infect Dis, 27(1): 3-15. [Abstract] [Full-text]
45. Multivariate Markov Process Models for the Transmission of Methicillin-Resistant Staphylococcus Aureus in a Hospital Ward.
    Biometrics. [Abstract] [Full-text]

© 2004-2008 MRSA Research Today. All Rights Reserved.